Ionpath

Menlo Park, United States Founded: 2014 • Age: 12 yrs
Multiplexed ion beam imaging platform for tissue biopsies is developed.
Request Access

About Ionpath

Ionpath is a company based in Menlo Park (United States) founded in 2014.. Ionpath has raised $18 million across 3 funding rounds from investors including Thermo Fisher Scientific, Bruker and Samsara BioCapital. The company has 37 employees as of December 31, 2020. Ionpath operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, Scholar Rock, SpectraWAVE and IBA, among others.

  • Headquarter Menlo Park, United States
  • Employees 37 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ionpath, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $18 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    37

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Ionpath
Headcount 50-200
Employee Profiles 10
Board Members and Advisors 5
Employee Profiles
People
Sweta Bajaj
Computer Vision, Data Scientist
People
Frank Tucker
Vice President Of Engineering
People
Raghav Padmanabhan
Senior Director Of Data Science
People
Xinyue He
Vice President Finance

Unlock access to complete

Board Members and Advisors
people
Frank Lee
Director
people
Mike Dybbs
Director
people
Paul Conley
Director
people
Garry Nolan
Co-Founder

Unlock access to complete

Funding Insights of Ionpath

Ionpath has successfully raised a total of $18M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round
  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2022 Amount Series B - Ionpath Valuation Thermo Fisher Scientific
Sep, 2020 Amount Series B - Ionpath Valuation Samsara BioCapital
Aug, 2017 Amount Seed - Ionpath Valuation Agile Angel
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ionpath

Ionpath has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Bruker and Samsara BioCapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital funding is provided by Samsara BioCapital in California.
Founded Year Domain Location
Early-stage VC firm focused on life science startups
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ionpath

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ionpath

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ionpath Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ionpath

Ionpath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, Scholar Rock, SpectraWAVE and IBA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Technology tools and systems for molecular scale are developed.
domain founded_year HQ Location
Imaging solutions for macro, micro, and nano structures are provided.
domain founded_year HQ Location
Antibody-based drugs for primary myopathies are developed and targeted.
domain founded_year HQ Location
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
domain founded_year HQ Location
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
domain founded_year HQ Location
A surgical digital microscope for tumor resection is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ionpath

Frequently Asked Questions about Ionpath

When was Ionpath founded?

Ionpath was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is Ionpath located?

Ionpath is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Who is the current CEO of Ionpath?

Paul Davy is the current CEO of Ionpath.

Is Ionpath a funded company?

Ionpath is a funded company, having raised a total of $18M across 3 funding rounds to date.

How many employees does Ionpath have?

As of Dec 31, 2020, the latest employee count at Ionpath is 37.

What does Ionpath do?

Developer of an imaging platform for tissue biopsies. It has designed a mass spec-based imaging platform for tissue biopsy called multiplexed ion beam imaging. The platform allows higher resolution and more samples can be screened simultaneously than the optical microscope and other mass spec-based imaging systems. The technology has diverse applications and can be used in research as well as diagnostic sectors.

Who are the top competitors of Ionpath?

Ionpath's top competitors include Oxford Instruments, Scholar Rock and Leica Microsystems.

Who are Ionpath's investors?

Ionpath has 8 investors. Key investors include Thermo Fisher Scientific, Bruker, Samsara BioCapital, Genoa Ventures, and Norwich Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available